Nearshore Protein: Stock Price Experiences Abnormal Fluctuations with Losses in Q1 of Both 2025 and 2026

The announcement from Nearshore Protein states that the company's stock price increased by more than 30% cumulatively over three consecutive trading days on August 6, August 7, and August 10, 2026, which constitutes abnormal fluctuation. After self-inspection, the company and its controlling shareholder and actual controller have found no significant information that should have been disclosed but was not, and current production and operations are normal. In 2025, revenue was 146.4395 million yuan, an increase of 14.80% year-on-year, with a net loss of 77.7834 million yuan; in the first quarter of 2026, revenue was 37.2467 million yuan, an increase of 11.37% year-on-year, with a net loss of 10.6044 million yuan. The company has a small operating scale and faces risks of loss, reminding investors to be cautious of trading risks.